Understanding how certain proteins affect blood stem cells
GPRASP family as novel regulators in hematopoietic stem cells
This research aims to discover how specific proteins called GPRASPs influence blood stem cells, hoping to make stem cell transplants more successful for people with blood diseases.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-11131088 on NIH RePORTER |
What this research studies
For many blood diseases like leukemia, a stem cell transplant is the only cure, but these transplants don't always work as well as we'd like. This project looks at how transplanted stem cells settle in and grow, especially when the body is under stress after a transplant. We are focusing on a family of proteins called GPRASPs, which appear to play a role in how well stem cells survive and function during this critical time. By understanding these proteins better, we hope to find new ways to improve the success of stem cell transplants.
Who could benefit from this research
Good fit: This foundational research is for future patients with serious blood diseases, such as leukemia, who require or may benefit from hematopoietic stem cell transplantation.
Not a fit: Patients who do not have blood diseases requiring stem cell transplantation would not directly benefit from this specific research.
Why it matters
Potential benefit: If successful, this work could lead to new strategies for improving the effectiveness of hematopoietic stem cell transplantation, especially for patients with limited cell numbers or those undergoing gene therapy.
How similar studies have performed: While the specific role of GPRASP proteins in stem cell transplantation is a novel area of focus, the broader field of improving stem cell engraftment has seen ongoing research and incremental successes.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Morales-Hernandez, Antonio — University of Michigan at Ann Arbor
- Study coordinator: Morales-Hernandez, Antonio
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.